Back

Voronoi withdraws Canadian CTA for VRN110755, plans resubmission

Verifying
  • Voronoi withdrew its Canadian Phase 1/2 CTA application for VRN110755.
  • August 7 submission was withdrawn after about one month of Health Canada review.
  • Voronoi plans to resubmit after updating the Investigator's Brochure.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.